Mr. Shaw has extensive experience with formulating winning corporate strategies, including vaccine development and negotiation of many substantive strategic partnerships, acquisitions and public offerings. He has broad international and domestic experience in product development, biotechnology start-ups as well as “turn-arounds”.

Dr. Lobo has a PhD in biochemistry, a degree in Pharmacy and two postdoctoral degrees. She is widely published in the fields of biochemistry, molecular biology and biological and metabolic pathways. She combines an extensive list of publications and patents with extensive commercial experience in the area of vaccine development. She is an adjunct professor at the University of Minnesota, Department of Surgery.